Department of Gastroenterology and Hepatology, Westmead Hospital, Sydney, New South Wales, Australia.
Institute of Clinical Pathology and Medical Research, Westmead Hospital, Sydney, New South Wales, Australia.
Gastrointest Endosc. 2017 Mar;85(3):518-526. doi: 10.1016/j.gie.2016.06.031. Epub 2016 Jun 22.
EMR of large laterally spreading lesions (LSL) in the colon is a safe and effective alternative to surgery. Post-EMR scar assessment currently involves taking biopsy specimens of the scar to detect residual or recurrent adenoma (RRA). The accuracy of endoscopic imaging of the post-EMR scar is unknown. We aimed to determine the accuracy of a standardized imaging protocol in post-EMR scar assessment.
Prospective, single-center data from the Australian Colonic EMR study were analyzed. Consecutive patients undergoing first surveillance colonoscopy (SC1) after EMR of a large LSL were eligible. All scars were sequentially examined with high-definition white light (HD-WL) and narrow-band imaging (NBI) in a standardized fashion and then biopsies were performed. Endoscopic recurrence (recurrence at the post-EMR scar detected by systematic endoscopic assessment) was compared with the histologic findings.
One hundred eighty-three post-EMR scars were included. Thirty of 183 (16.4%) were confirmed to have RRA histologically at SC1. Thirty-seven of 183 (20.2%) post-EMR scars demonstrated RRA endoscopically. The sensitivity and specificity of endoscopic RRA detection were 93.3% (95% confidence interval [CI], 77.9%-99.2%) and 94.1% (95% CI, 89.1%-97.3%), respectively. The positive predictive value was 75.7% (95% CI, 58.8%-88.2%) and the negative predictive value was 98.6% (95% CI, 95.1%-99.8%). The diagnostic accuracy was 94.0%. Sensitivity was higher for the combination of HD-WL and NBI as opposed to HD-WL alone (93.3% vs 66.7%). The specificity was high for both HD-WL and HD-WL + NBI (96.1% and 94.1%, respectively). Flat morphology of RRA was better seen with NBI (P = .002).
Endoscopic detection of RRA in the post-EMR scar is highly accurate using a standardized imaging protocol with HD-WL and NBI. This allows real-time, accurate detection of recurrence and its concurrent treatment, and raises the possibility that routine biopsy of the post-EMR scar may not be necessary.
结肠中大型侧向扩展病变(LSL)的内镜黏膜切除术(EMR)是一种安全有效的手术替代方法。目前,对 EMR 后疤痕的评估包括对疤痕进行活检以检测残留或复发性腺瘤(RRA)。EMR 后疤痕内镜成像的准确性尚不清楚。我们旨在确定标准化成像方案在 EMR 后疤痕评估中的准确性。
对澳大利亚结肠 EMR 研究的前瞻性、单中心数据进行了分析。符合条件的是接受大型 LSL EMR 后首次监测结肠镜检查(SC1)的连续患者。所有疤痕均采用高清白光(HD-WL)和窄带成像(NBI)以标准化方式连续检查,然后进行活检。内镜复发(通过系统内镜评估在 EMR 后疤痕处检测到的复发)与组织学发现进行比较。
共纳入 183 个 EMR 后疤痕。在 SC1 时,30/183(16.4%)的疤痕组织学证实存在 RRA。183 个 EMR 后疤痕中有 37 个(20.2%)在镜下显示 RRA。内镜 RRA 检测的灵敏度和特异性分别为 93.3%(95%CI,77.9%-99.2%)和 94.1%(95%CI,89.1%-97.3%)。阳性预测值为 75.7%(95%CI,58.8%-88.2%),阴性预测值为 98.6%(95%CI,95.1%-99.8%)。诊断准确性为 94.0%。与单独使用 HD-WL 相比,HD-WL 和 NBI 联合使用的灵敏度更高(93.3% vs 66.7%)。HD-WL 和 HD-WL+NBI 的特异性均较高(分别为 96.1%和 94.1%)。NBI 更能清晰显示 RRA 的平坦形态(P=0.002)。
使用 HD-WL 和 NBI 的标准化成像方案,内镜检测 EMR 后疤痕中的 RRA 具有高度准确性。这可以实时、准确地检测复发及其并发治疗,并提出了 EMR 后疤痕常规活检可能不必要的可能性。